Ionis Pharmaceuticals Inc (IONS) stock
IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/301% below fair value
$28.01−1.05 (-3.61%)
Close on Nov 16, 2026Market cap $4.65BP/E –Yield –
Ionis Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Ionis Pharmaceuticals's cash was $2.05B at Jun 30, 2026. For fiscal 2025 it was $2.68B, up 16.5% from the year before. Over ten years it grew 13.1% a year on average. The highest annual figure on record is $2.68B in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.68B | +16.5% |
| FY2024 | Dec 31, 2024 | $2.30B | -1.4% |
| FY2023 | Dec 31, 2023 | $2.33B | +17.3% |
| FY2022 | Dec 31, 2022 | $1.99B | -6.1% |
| FY2021 | Dec 31, 2021 | $2.11B | +11.8% |
| FY2020 | Dec 31, 2020 | $1.89B | -24.3% |
| FY2019 | Dec 31, 2019 | $2.50B | +19.9% |
| FY2018 | Dec 31, 2018 | $2.08B | +103.8% |
| FY2017 | Dec 31, 2017 | $1.02B | +53.7% |
| FY2016 | Dec 31, 2016 | $665.22M | -14.6% |
| FY2015 | Dec 31, 2015 | $779.18M | +6.9% |
| FY2014 | Dec 31, 2014 | $728.83M | +11.0% |
| FY2013 | Dec 31, 2013 | $656.76M | +75.4% |
| FY2012 | Dec 31, 2012 | $374.45M | +9.0% |
| FY2011 | Dec 31, 2011 | $343.66M | -27.2% |
| FY2010 | Dec 31, 2010 | $472.35M | +348.8% |
| FY2009 | Dec 31, 2009 | $105.26M | -53.0% |
| FY2008 | Dec 31, 2008 | $223.99M | +61.6% |
| FY2007 | Dec 31, 2007 | $138.61M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.05B | -10.3% |
| Q1 FY2026 | Mar 31, 2026 | $1.92B | -10.5% |
| Q4 FY2025 | Dec 31, 2025 | $2.68B | +16.5% |
| Q3 FY2025 | Sep 30, 2025 | $2.24B | -9.8% |
| Q2 FY2025 | Jun 30, 2025 | $2.29B | +10.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.15B | -2.8% |
| Q4 FY2024 | Dec 31, 2024 | $2.30B | -1.4% |
| Q3 FY2024 | Sep 30, 2024 | $2.48B | +11.1% |
| Q2 FY2024 | Jun 30, 2024 | $2.08B | -12.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.21B | -6.0% |
| Q4 FY2023 | Dec 31, 2023 | $2.33B | +17.3% |
| Q3 FY2023 | Sep 30, 2023 | $2.24B | +12.8% |
| Q2 FY2023 | Jun 30, 2023 | $2.39B | +18.0% |
| Q1 FY2023 | Mar 31, 2023 | $2.35B | +14.3% |
| Q4 FY2022 | Dec 31, 2022 | $1.99B | -6.1% |
| Q3 FY2022 | Sep 30, 2022 | $1.98B | -0.3% |
| Q2 FY2022 | Jun 30, 2022 | $2.02B | -1.8% |
| Q1 FY2022 | Mar 31, 2022 | $2.05B | +12.8% |
| Q4 FY2021 | Dec 31, 2021 | $2.11B | +11.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.99B | -14.7% |
| Q2 FY2021 | Jun 30, 2021 | $2.06B | -12.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.82B | -23.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.89B | -24.3% |
| Q3 FY2020 | Sep 30, 2020 | $2.33B | +4.9% |
| Q2 FY2020 | Jun 30, 2020 | $2.35B | +3.8% |
| Q1 FY2020 | Mar 31, 2020 | $2.38B | +5.8% |
| Q4 FY2019 | Dec 31, 2019 | $2.50B | +19.9% |
| Q3 FY2019 | Sep 30, 2019 | $2.22B | +13.4% |
| Q2 FY2019 | Jun 30, 2019 | $2.26B | +14.2% |
| Q1 FY2019 | Mar 31, 2019 | $2.25B | +117.7% |
| Q4 FY2018 | Dec 31, 2018 | $2.08B | +103.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.96B | +93.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.98B | +131.4% |
| Q1 FY2018 | Mar 31, 2018 | $1.04B | +20.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.02B | +53.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.01B | +47.0% |
| Q2 FY2017 | Jun 30, 2017 | $855.71M | – |
| Q1 FY2017 | Mar 31, 2017 | $860.28M | – |
| Q4 FY2016 | Dec 31, 2016 | $665.22M | – |
| Q3 FY2016 | Sep 30, 2016 | $687.85M | – |
See a number that looks wrong?